CenturyLink, Inc.

We are investigating CenturyLink, Inc. (NYSE: CTL) regarding the NOL Rights Plan between CenturyLink and Computershare Trust Company, N.A., where each share of CenturyLink common stock will carry with it one preferred share purchase right.

GTx, Inc.

We are investigating GTx, Inc. (NasdaqCM: GTXI) (“GTx”) regarding the merger agreement between GTx and Oncternal Therapeutics, Inc., where GTx stockholders will own approximately 25% of the combined company.

HFF, Inc.

We are investigating HFF, Inc. (NYSE: HF) (“HFF”) regarding the sale of HFF to Jones Lang LaSalle Incorporated (“JLL”), where HFF shareholders will receive $24.63 in cash and 0.1505 shares of JLL for each share of HFF they own.

Uniti Financial Corporation

We are investigating the Board of Directors of Uniti Financial Corporation (OTC: UIFC) related to the sale of the company to BayCom Corp. Under the terms of the proposed transaction, each share of Uniti common stock will be converted into the right to receive (i) $2.30 in cash and (ii) 0.07234 shares of BayCom common … Read more

AmpliPhi Biosciences Corporation

We are investigating the Board of Directors of AmpliPhi Biosciences Corporation (NYSE: APHB) related to the sale of the Company to C3J Therapeutics, Inc. Under the terms of the proposed transaction, AmpliPhi stockholders will own 30% of AmpliPhi common stock upon completion of the transaction.

Nightstar Therapeutics plc

We are investigating the sale of Nightstar Therapeutics plc (NasdaqGS: NITE) to Biogen Switzerland Holdings GmhH. Under the terms of the proposed transaction, Nightstar stockholders will receive $25.50 in cash for each Nightstar share they own.

Coty, Inc.

We are investigating Coty, Inc. (NYSE: COTY) (“Coty”) regarding the tender offer Coty received from Cottage Holdco B.V. (“Cottage”), where Cottage will acquire up to 150 million shares of the Company’s Class A common stock at a price of $11.65 per share in cash.

Osiris Therapeutics, Inc.

We are investigating Osiris Therapeutics, Inc. (NasdaqGM: OSIR) relating to the sale of the Company to Smith & Nephew plc. Under the transaction, Osiris shareholders will receive $19.00 in cash for each share of Osiris stock they hold.

Newmont Mining Corporation

We are investigating the Board of Directors of Newmont Mining Corporation (NYSE: NEM) related to the Company’s acquisition of Goldcorp Inc. Under the terms of the proposed transaction, Goldcorp shareholders will receive 0.3280 of a share of Newmont common stock and $0.02 in cash for each Goldcorp common share.

Bemis Company, Inc.

We are investigating the Board of Directors of Bemis Company, Inc. (NYSE: BMS) related to the sale of the company to Amcor plc. Under the terms of the proposed transaction, Bemis shareholders will receive 5.1 shares of Amcor plc stock for each share of Bemis stock they own.